Feng, H.; Feng, J.; Han, X.; Ying, Y.; Lou, W.; Liu, L.; Zhang, L.
The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy. Cancers 2024, 16, 289.
https://doi.org/10.3390/cancers16020289
AMA Style
Feng H, Feng J, Han X, Ying Y, Lou W, Liu L, Zhang L.
The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy. Cancers. 2024; 16(2):289.
https://doi.org/10.3390/cancers16020289
Chicago/Turabian Style
Feng, Haokang, Jiale Feng, Xu Han, Ying Ying, Wenhui Lou, Liang Liu, and Lei Zhang.
2024. "The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy" Cancers 16, no. 2: 289.
https://doi.org/10.3390/cancers16020289
APA Style
Feng, H., Feng, J., Han, X., Ying, Y., Lou, W., Liu, L., & Zhang, L.
(2024). The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy. Cancers, 16(2), 289.
https://doi.org/10.3390/cancers16020289